These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35879378)

  • 1. Impact of treatment modalities on prognosis of patients with metastatic renal collecting duct carcinoma.
    Qian X; Wan J; Tan Y; Liu Z; Zhang Y
    Sci Rep; 2022 Jul; 12(1):12678. PubMed ID: 35879378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Treatment Modalities on Prognosis in Patients With Renal Collecting Duct Carcinoma: A Population-Based Study.
    Qian X; Xu J; Liu C; Zhong M; Hong S; Qian C; Zhu J; Zhang J; Wang S
    Front Oncol; 2022; 12():810096. PubMed ID: 35530344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic Outcomes of Cytoreductive Nephrectomy in Synchronous Metastatic Renal-Cell Carcinoma: A Single-Center Experience.
    Choi CI; Kang M; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SIL
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1189-e1199. PubMed ID: 30262447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study.
    Chen WK; Wu ZG; Xiao YB; Wang QQ; Yu DD; Cai J; Zhou CF
    Technol Cancer Res Treat; 2021; 20():15330338211004914. PubMed ID: 33929915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.
    Xiao R; Liu C; He W; Ma L
    Biomed Res Int; 2021; 2021():6736008. PubMed ID: 34805402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Population Study to Identify Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Sarcomatoid Renal Cell Carcinoma from the Surveillance, Epidemiology, and End Results (SEER) Database.
    Ji B; Li D; Fu S; Zhang Z; Yang T; Wu Y; Zuo Y; Xu Z; Yu N
    Med Sci Monit; 2020 Jun; 26():e921297. PubMed ID: 32516796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytoreductive Partial Nephrectomy versus Cytoreductive Radical Nephrectomy for Locally T
    Xiong SC; Shao YX; Hu X; Yang WX; Dou WC; Li X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 51(4):546-551. PubMed ID: 32691565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collecting duct carcinoma: Epidemiology, clinical characteristics and survival.
    Panunzio A; Tappero S; Hohenhorst L; Cano Garcia C; Piccinelli M; Barletta F; Tian Z; Tafuri A; Briganti A; De Cobelli O; Chun FKH; Tilki D; Terrone C; Kapoor A; Saad F; Shariat SF; Cerruto MA; Antonelli A; Karakiewicz PI
    Urol Oncol; 2023 Feb; 41(2):110.e7-110.e14. PubMed ID: 36456452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and prognosis of metastatic collecting duct carcinoma.
    Zhou L; Liu Y; Mo J; Cui C; Chi Z; Si L; Kong Y; Yan X; Li S; Wu X; Li J; Xu H; Cao D; Guo J; Sheng X
    Urol Oncol; 2022 Aug; 40(8):385.e1-385.e8. PubMed ID: 35773144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic Patterns and Prognosis of de novo Metastatic Nasopharyngeal Carcinoma in the United States.
    Xu Y; Huang T; Mao M; Zhai J; Chen J
    Laryngoscope; 2021 Apr; 131(4):E1130-E1138. PubMed ID: 32833262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of cytoreductive surgery for metastatic upper tract urothelial carcinoma: a Surveillance, Epidemiology and End Results (SEER) study of 508 patients.
    Hu H; Lai S; Ni R; Wang M; Lai C; Ji J; Xu T; Hu H
    Transl Androl Urol; 2024 Jun; 13(6):983-993. PubMed ID: 38983475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of targeted therapy on management of metastatic renal cell carcinoma: trends in systemic therapy and cytoreductive nephrectomy utilization.
    Psutka SP; Kim SP; Gross CP; Van Houten H; Thompson RH; Abouassaly R; Weight C; Boorjian SA; Leibovich BC; Shah ND
    Urology; 2015 Feb; 85(2):442-50. PubMed ID: 25623717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
    Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
    Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience.
    Qi N; Wu P; Chen J; Li T; Ning X; Wang J; Gong K
    World J Surg Oncol; 2017 Jan; 15(1):4. PubMed ID: 28056988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival prognoses of Heng intermediate-risk patients with metastatic renal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study.
    Kim SH; Lee DE; Joung JY; Seo HK; Lee KH; Chung J
    Investig Clin Urol; 2020 Mar; 61(2):146-157. PubMed ID: 32158965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Primary Tumor Size on Prognosis in Patients With Metastatic Renal Cell Carcinoma Receiving Cytoreductive Nephrectomy: A Population Study of a Chinese Center and the US SEER Database.
    Jiang W; Shou J; Shi H; Wen L; Zhang H; Zheng S; Li C; Ma J
    Technol Cancer Res Treat; 2021; 20():15330338211019507. PubMed ID: 34032149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic nomogram for patients with lung metastatic renal cell carcinoma: a SEER-based study.
    Mao W; Fu Z; Wang K; Wu J; Xu B; Chen M
    Ann Palliat Med; 2021 Mar; 10(3):2791-2804. PubMed ID: 33549017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms.
    Yi Z; Liu R; Hu J; He T; Wang Z; Li Y; Zu X
    Clin Genitourin Cancer; 2021 Apr; 19(2):155-161. PubMed ID: 33288452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of different metastatic sites for patients with FIGO stage IVB endometrial cancer after surgery: A SEER database analysis.
    Li H; Zhang R; Chen C; Wu C; Lin H; Li J; Lin Z
    J Surg Oncol; 2020 Oct; 122(5):941-948. PubMed ID: 32682330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.